Skip to content
lifestyle.smarttalksuccess.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BioInvent International
BioInvent International AB: Interim Report January – March 2026
May 5, 2026
BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
May 4, 2026
BioInvent International AB Publishes Annual Report 2025
May 2, 2026
BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis
May 1, 2026
BioInvent International AB: Year-End Report January 1 – December 31, 2025
February 26, 2026
Invitation to Presentation of BioInvent’s Year-End Report 2025
February 26, 2026
BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting
February 23, 2026
←
Previous Page
1
2